Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Jiuxu Pharmaceutical Technology Co., Ltd. is a pharmaceutical enterprise based in the Hainan Free Trade Port, China, and serves as a core subsidiary of the Jiuxu Pharmaceutical Group. The company focuses on the research, development, and large-scale production of high-end chemical injections, biological products, and modernized traditional Chinese medicines. Its commercial portfolio is primarily centered on therapeutic solutions for cardiovascular and cerebrovascular diseases, as well as anti-infective treatments. Hainan Jiuxu leverages the regional policy advantages of Hainan to advance its manufacturing capabilities and technological innovation in drug delivery systems. The company is a significant player in the Chinese domestic hospital market, particularly in the emergency and critical care segments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hai Nan Jiu Xu Yi Yao Ke Ji You Xian Gong Si.